These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

976 related items for PubMed ID: 23036338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vismodegib (Erivedge) for basal cell carcinoma.
    Med Lett Drugs Ther; 2012 Jul 09; 54(1394):53-4. PubMed ID: 22777303
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
    Dessinioti C, Plaka M, Stratigos AJ.
    Future Oncol; 2014 May 09; 10(6):927-36. PubMed ID: 24941979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vismodegib for periocular and orbital basal cell carcinoma.
    Gill HS, Moscato EE, Chang AL, Soon S, Silkiss RZ.
    JAMA Ophthalmol; 2013 Dec 09; 131(12):1591-4. PubMed ID: 24136169
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P, Williams JS, Brownell I.
    J Drugs Dermatol; 2013 May 09; 12(5):519-23. PubMed ID: 23652945
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vismodegib: a promising drug in the treatment of basal cell carcinomas.
    Dirix L, Rutten A.
    Future Oncol; 2012 Aug 09; 8(8):915-28. PubMed ID: 22894666
    [Abstract] [Full Text] [Related]

  • 16. Vismodegib (ERIVEDGE°) In basal cell carcinoma: too many unknowns.
    Prescrire Int; 2015 Jan 09; 24(156):11-4. PubMed ID: 25729822
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.